Search clinical trials for: HGP0918 HGP0816

Total 34 results

Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

Primary Hypercholesterolemia
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers

Hyperlipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

Hyperlipidemias

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of HCP1102 Capsule

Asthma With Allergic Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Healthy
Hanmi Pharmaceutical Company Limited

Completed

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403, HGP0919

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Trial to Evaluate the Efficacy and Safety of HCP1302

Hypertension | Erectile Dysfunction
Hanmi Pharmaceutical Company Limited

Unknown

Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Chronic Obstructive Pulmonary Disease
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

Healthy

Korea, Republic of
Suzhou Kintor Pharmaceutical Inc,

Terminated

A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

COVID-19

Brazil
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
Suzhou Kintor Pharmaceutical Inc,

Completed

Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness

Efficacy and Safety

United States
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

Health, Subjective

Korea, Republic of
Galderma R&D

Active, not recruiting

Study to Evaluate the Safety and Effectiveness of GP0116 (NLF)

Skin Manifestations

United States
Suzhou Kintor Pharmaceutical Inc,

Terminated

A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Covid19

United States, China, Philippines, South Africa, Ukraine
Hanmi Pharmaceutical Company Limited
Seoul National University Bundang Hospital

Completed

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Hypertension(HTN)

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Erectile Dysfunction

Korea, Republic of
Suzhou Kintor Pharmaceutical Inc,

Completed

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Suzhou Kintor Pharmaceutical Inc,

Completed

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

United States
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Asthma

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Healthy

Korea, Republic of
Seoul National University Hospital

Completed

Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)

Pulmonary Disease, Chronic Obstructive

Korea, Republic of

3

Subscribe